203 related articles for article (PubMed ID: 36519208)
1. Identifying the key genes of Epstein-Barr virus-regulated tumour immune microenvironment of gastric carcinomas.
Zhou H; Jing S; Liu Y; Wang X; Duan X; Xiong W; Li R; Peng Y; Ai Y; Fu D; Wang H; Zhu Y; Zeng Z; He Y; Ye Q
Cell Prolif; 2023 Mar; 56(3):e13373. PubMed ID: 36519208
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Epstein-Barr Virus Genomes and Expression Profiles in Gastric Adenocarcinoma.
Borozan I; Zapatka M; Frappier L; Ferretti V
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093097
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori and Epstein-Barr Virus Coinfection Stimulates Aggressiveness in Gastric Cancer through the Regulation of Gankyrin.
Kashyap D; Baral B; Jakhmola S; Singh AK; Jha HC
mSphere; 2021 Oct; 6(5):e0075121. PubMed ID: 34585958
[TBL] [Abstract][Full Text] [Related]
4. Interaction of Epstein-Barr virus genes with human gastric carcinoma transcriptome.
Zhang R; Strong MJ; Baddoo M; Lin Z; Wang YP; Flemington EK; Liu YZ
Oncotarget; 2017 Jun; 8(24):38399-38412. PubMed ID: 28415594
[TBL] [Abstract][Full Text] [Related]
5. Screening and identification of key genes in EBV-associated gastric carcinoma based on bioinformatics analysis.
Wang H; Zhou L; Yang Y; Luo B
Pathol Res Pract; 2021 Jun; 222():153439. PubMed ID: 34020134
[TBL] [Abstract][Full Text] [Related]
6. Loss of viral genome with altered immune microenvironment during tumour progression of Epstein-Barr virus-associated gastric carcinoma.
Kondo A; Shinozaki-Ushiku A; Rokutan H; Kunita A; Ikemura M; Yamashita H; Seto Y; Nagae G; Tatsuno K; Aburatani H; Koinuma D; Ushiku T
J Pathol; 2023 Jun; 260(2):124-136. PubMed ID: 36806225
[TBL] [Abstract][Full Text] [Related]
7. Expression of Epstein-Barr virus genes in EBV-associated gastric carcinomas.
Luo B; Wang Y; Wang XF; Liang H; Yan LP; Huang BH; Zhao P
World J Gastroenterol; 2005 Feb; 11(5):629-33. PubMed ID: 15655811
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus and gastric carcinoma.
Fukayama M
Pathol Int; 2010 May; 60(5):337-50. PubMed ID: 20518883
[TBL] [Abstract][Full Text] [Related]
9. Clinical and pathological characterization of Epstein-Barr virus-associated gastric carcinomas in Portugal.
Ribeiro J; Oliveira A; Malta M; Oliveira C; Silva F; Galaghar A; Afonso LP; Neves MC; Medeiros R; Pimentel-Nunes P; Sousa H
World J Gastroenterol; 2017 Oct; 23(40):7292-7302. PubMed ID: 29142476
[TBL] [Abstract][Full Text] [Related]
10. A novel biomarker associated with EBV infection improves response prediction of immunotherapy in gastric cancer.
Li X; Xiong F; Hu Z; Tao Q; Yang Y; Qiao X; Peng C; Jiang Y; Han M; Dong K; Hua Y; Zhang W; Xu M; Long W; Xiao Y; Wang D
J Transl Med; 2024 Jan; 22(1):90. PubMed ID: 38254099
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus encoded miR-BART11 promotes inflammation-induced carcinogenesis by targeting FOXP1.
Song Y; Li X; Zeng Z; Li Q; Gong Z; Liao Q; Li X; Chen P; Xiang B; Zhang W; Xiong F; Zhou Y; Zhou M; Ma J; Li Y; Chen X; Li G; Xiong W
Oncotarget; 2016 Jun; 7(24):36783-36799. PubMed ID: 27167345
[TBL] [Abstract][Full Text] [Related]
12. Differences in gastric carcinoma microenvironment stratify according to EBV infection intensity: implications for possible immune adjuvant therapy.
Strong MJ; Xu G; Coco J; Baribault C; Vinay DS; Lacey MR; Strong AL; Lehman TA; Seddon MB; Lin Z; Concha M; Baddoo M; Ferris M; Swan KF; Sullivan DE; Burow ME; Taylor CM; Flemington EK
PLoS Pathog; 2013; 9(5):e1003341. PubMed ID: 23671415
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus and gastric carcinoma: virus-host interactions leading to carcinoma.
Fukayama M; Hino R; Uozaki H
Cancer Sci; 2008 Sep; 99(9):1726-33. PubMed ID: 18616681
[TBL] [Abstract][Full Text] [Related]
14. Recognizing the role of Epstein-Barr virus in gastric cancer: transcriptomic insights into malignancy modulation.
Anbouhi TS; Sazegar H; Rahimi E
Virol J; 2024 Feb; 21(1):41. PubMed ID: 38355581
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Epstein-Barr Virus Infection and Mismatch Repair Protein Deficiency and the Correlation of Immune Markers in Tibetan Patients with Gastric Cancer.
Shi J; Yang X; Wang X; Luo Y; Zhou W; Luo H; Bianba Z; Nima Z; Wang Q; Wang H; Liao R; Ciren Q; Li M; Pang J
Biomed Res Int; 2022; 2022():2684065. PubMed ID: 35734348
[TBL] [Abstract][Full Text] [Related]
16. Zinc finger E-box binding factor 1 plays a central role in regulating Epstein-Barr virus (EBV) latent-lytic switch and acts as a therapeutic target in EBV-associated gastric cancer.
Zhao J; Jin H; Cheung KF; Tong JH; Zhang S; Go MY; Tian L; Kang W; Leung PP; Zeng Z; Li X; To KF; Sung JJ; Yu J
Cancer; 2012 Feb; 118(4):924-36. PubMed ID: 21717425
[TBL] [Abstract][Full Text] [Related]
17. Determination and genome-wide analysis of Epstein-Barr virus (EBV) sequences in EBV-associated gastric carcinoma from Guangdong, an endemic area of nasopharyngeal carcinoma.
Chen JN; Zhou L; Qiu XM; Yang RH; Liang J; Pan YH; Li HF; Peng GR; Shao CK
J Med Microbiol; 2018 Nov; 67(11):1614-1627. PubMed ID: 30239329
[TBL] [Abstract][Full Text] [Related]
18. Autocrine growth of Epstein-Barr virus-positive gastric carcinoma cells mediated by an Epstein-Barr virus-encoded small RNA.
Iwakiri D; Eizuru Y; Tokunaga M; Takada K
Cancer Res; 2003 Nov; 63(21):7062-7. PubMed ID: 14612496
[TBL] [Abstract][Full Text] [Related]
19. PD-L1 overexpression in EBV-positive gastric cancer is caused by unique genomic or epigenomic mechanisms.
Nakano H; Saito M; Nakajima S; Saito K; Nakayama Y; Kase K; Yamada L; Kanke Y; Hanayama H; Onozawa H; Okayama H; Fujita S; Sakamoto W; Saze Z; Momma T; Mimura K; Ohki S; Goto A; Kono K
Sci Rep; 2021 Jan; 11(1):1982. PubMed ID: 33479394
[TBL] [Abstract][Full Text] [Related]
20. [Gastric carcinoma is the most frequent Epstein-Barr virus-associated malignancy].
Boysen T; Friborg J
Ugeskr Laeger; 2013 Nov; 175(47A):. PubMed ID: 25353091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
